Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Nov;101(3):715–721. doi: 10.1111/j.1476-5381.1990.tb14146.x

The effects of 5-HT on articular sensory receptors in normal and arthritic rats.

G J Birrell 1, D S McQueen 1, A Iggo 1, B D Grubb 1
PMCID: PMC1917759  PMID: 2076487

Abstract

1. The effects of intra arterial (i.a.) injections of 5-hydroxytryptamine (5-HT, 1-100 micrograms) on the discharge of (a) identified articular high threshold mechanoreceptors and (b) unidentified chemosensitive receptors in the ankle joint have been studied electrophysiologically in anaesthetized normal and arthritic rats. Recordings were made from a fine branch of the medial plantar nerve. 2. 5-HT increased the mechanical responsiveness of high threshold nociceptive mechanoreceptors with C and A delta fibre afferents in both normal and adjuvant-arthritic rats. Receptors in arthritic joints were more sensitive to 5-HT than were those from normal joints. 3. 5-HT produced a complex response from both types of articular receptors following i.a. injection. Two separate components were identified: (a) a fast transient burst of activity was obtained within 10 s of this injection in 66% of units from normal animals and 45% from arthritics, followed by (b) a delayed slow longer-lasting excitation seen in 62% of the units examined from normals and 77% of units from arthritic rats. 4. Increased mechanoreceptor responsiveness produced by 5-HT was reduced or abolished by the 5-HT3 receptor antagonists studied (MDL 72222, ICS 205-930, or GR 38032F, in single doses of 100 micrograms kg-1, i.a.). 5. Fast excitation showed marked tachyphylaxis and was antagonized by MDL 72222, ICS 205-930 or GR 38032F. It was unaffected by ketanserin (100 micrograms kg-1, i.a.). Delayed excitation was reduced or abolished by ketanserin but was unaffected by the 5-HT3-receptor antagonists.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
721

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azami J., Fozard J. R., Round A. A., Wallis D. I. The depolarizing action of 5-hydroxytryptamine on rabbit vagal primary afferent and sympathetic neurones and its selective blockade by MDL 72222. Naunyn Schmiedebergs Arch Pharmacol. 1985 Feb;328(4):423–429. doi: 10.1007/BF00692911. [DOI] [PubMed] [Google Scholar]
  2. Beck P. W., Handwerker H. O. Bradykinin and serotonin effects on various types of cutaneous nerve fibers. Pflugers Arch. 1974 Mar 11;347(3):209–222. doi: 10.1007/BF00592598. [DOI] [PubMed] [Google Scholar]
  3. Bradley P. B., Engel G., Feniuk W., Fozard J. R., Humphrey P. P., Middlemiss D. N., Mylecharane E. J., Richardson B. P., Saxena P. R. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology. 1986 Jun;25(6):563–576. doi: 10.1016/0028-3908(86)90207-8. [DOI] [PubMed] [Google Scholar]
  4. Colpaert F. C. Evidence that adjuvant arthritis in the rat is associated with chronic pain. Pain. 1987 Feb;28(2):201–222. doi: 10.1016/0304-3959(87)90117-5. [DOI] [PubMed] [Google Scholar]
  5. Dun N. J., Kiraly M., Ma R. C. Evidence for a serotonin-mediated slow excitatory potential in the guinea-pig coeliac ganglia. J Physiol. 1984 Jun;351:61–76. doi: 10.1113/jphysiol.1984.sp015232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eschalier A., Kayser V., Guilbaud G. Influence of a specific 5-HT3 antagonist on carrageenan-induced hyperalgesia in rats. Pain. 1989 Feb;36(2):249–255. doi: 10.1016/0304-3959(89)90030-4. [DOI] [PubMed] [Google Scholar]
  7. FJALLBRANT N., IGGO A. The effect of histamine, 5-hydroxytryptamine and acetylcholine on cutaneous afferent fibres. J Physiol. 1961 May;156:578–590. doi: 10.1113/jphysiol.1961.sp006694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fozard J. R. Neuronal 5-HT receptors in the periphery. Neuropharmacology. 1984 Dec;23(12B):1473–1486. doi: 10.1016/0028-3908(84)90091-1. [DOI] [PubMed] [Google Scholar]
  9. Grubb B. D., McQueen D. S., Iggo A., Birrell G. J., Dutia M. B. A study of 5-HT-receptors associated with afferent nerves located in normal and inflamed rat ankle joints. Agents Actions. 1988 Dec;25(3-4):216–218. doi: 10.1007/BF01965015. [DOI] [PubMed] [Google Scholar]
  10. Guilbaud G., Iggo A., Tegnér R. Sensory receptors in ankle joint capsules of normal and arthritic rats. Exp Brain Res. 1985;58(1):29–40. doi: 10.1007/BF00238950. [DOI] [PubMed] [Google Scholar]
  11. Guilbaud G., Iggo A. The effect of lysine acetylsalicylate on joint capsule mechanoreceptors in rats with polyarthritis. Exp Brain Res. 1985;61(1):164–168. doi: 10.1007/BF00235631. [DOI] [PubMed] [Google Scholar]
  12. Haefely W. The effects of 5-hydroxytryptamine and some related compounds on the cat superior cervical ganglion in situ. Naunyn Schmiedebergs Arch Pharmacol. 1974;281(2):145–165. doi: 10.1007/BF00503495. [DOI] [PubMed] [Google Scholar]
  13. Higashi H., Nishi S. 5-Hydroxytryptamine receptors of visceral primary afferent neurones on rabbit nodose ganglia. J Physiol. 1982 Feb;323:543–567. doi: 10.1113/jphysiol.1982.sp014091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Johnson A. R., Erdös E. G. Release of histamine from mast cells by vasoactive peptides. Proc Soc Exp Biol Med. 1973 Apr;142(4):1252–1256. doi: 10.3181/00379727-142-37219. [DOI] [PubMed] [Google Scholar]
  15. Kiraly M., Ma R. C., Dun N. J. Serotonin mediates a slow excitatory potential in mammalian celiac ganglia. Brain Res. 1983 Sep 26;275(2):378–383. doi: 10.1016/0006-8993(83)91002-8. [DOI] [PubMed] [Google Scholar]
  16. Kirby G. C., McQueen D. S. Effects of the antagonists MDL 72222 and ketanserin on responses of cat carotid body chemoreceptors to 5-hydroxytryptamine. Br J Pharmacol. 1984 Sep;83(1):259–269. doi: 10.1111/j.1476-5381.1984.tb10142.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mense S. Sensitization of group IV muscle receptors to bradykinin by 5-hydroxytryptamine and prostaglandin E2. Brain Res. 1981 Nov 23;225(1):95–105. doi: 10.1016/0006-8993(81)90320-6. [DOI] [PubMed] [Google Scholar]
  18. Nakano T., Taira N. 5-Hydroxytryptamine as a sensitizer of somatic nociceptors for pain-producing substances. Eur J Pharmacol. 1976 Jul;38(1):23–29. doi: 10.1016/0014-2999(76)90197-7. [DOI] [PubMed] [Google Scholar]
  19. Page C. P. The involvement of platelets in non-thrombotic processes. Trends Pharmacol Sci. 1988 Feb;9(2):66–71. doi: 10.1016/0165-6147(88)90120-4. [DOI] [PubMed] [Google Scholar]
  20. Richardson B. P., Engel G., Donatsch P., Stadler P. A. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature. 1985 Jul 11;316(6024):126–131. doi: 10.1038/316126a0. [DOI] [PubMed] [Google Scholar]
  21. Round A., Wallis D. I. Further studies on the blockade of 5-HT depolarizations of rabbit vagal afferent and sympathetic ganglion cells by MDL 72222 and other antagonists. Neuropharmacology. 1987 Jan;26(1):39–48. doi: 10.1016/0028-3908(87)90042-6. [DOI] [PubMed] [Google Scholar]
  22. Round A., Wallis D. I. The depolarizing action of 5-hydroxytryptamine on rabbit vagal afferent and sympathetic neurones in vitro and its selective blockade by ICS 205-930. Br J Pharmacol. 1986 Jun;88(2):485–494. doi: 10.1111/j.1476-5381.1986.tb10227.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wallis D. I., Dun N. J. A comparison of fast and slow depolarizations evoked by 5-HT in guinea-pig coeliac ganglion cells in vitro. Br J Pharmacol. 1988 Jan;93(1):110–120. doi: 10.1111/j.1476-5381.1988.tb11411.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wallis D. I., North R. A. The action of 5-hydroxytryptamine on single neurones of the rabbit superior cervical ganglion. Neuropharmacology. 1978 Dec;17(12):1023–1028. doi: 10.1016/0028-3908(78)90028-x. [DOI] [PubMed] [Google Scholar]
  25. Williams T. H. Electron microscopic evidence for an autonomic interneuron. Nature. 1967 Apr 15;214(5085):309–310. doi: 10.1038/214309b0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES